* Protein Sciences Inc., of Meriden, Conn., signed an agreement for use of its baculovirus expression vector system to manufacture CD4 proteins for Sequus Pharmaceuticals Inc., of Menlo Park, Calif. Sequus will combine the proteins with liposomes for treatment of AIDS. Financial terms of the alliance were not disclosed.
* Structural Bioinformatics Inc., of San Diego, and CyberChemics Inc., of Huntsville, Ala., formed a collaboration to develop protease inhibitors to attack viral infections. The companies initially will focus on a hepatitis C protease inhibitor. Financial terms were not disclosed.